212 related articles for article (PubMed ID: 23886689)
1. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors.
Adamek RN; Maniquis RV; Khakoo S; Bridges MD; Salzameda NT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4848-50. PubMed ID: 23886689
[TBL] [Abstract][Full Text] [Related]
2. Discovery, synthesis, and in vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3H,4aH-1,3,9,10a-tetraazaphenanthren-4-one scaffold.
Samanta S; Cui T; Lam Y
ChemMedChem; 2012 Jul; 7(7):1210-6. PubMed ID: 22550001
[TBL] [Abstract][Full Text] [Related]
3. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Nitsche C; Steuer C; Klein CD
Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
Samanta S; Lim TL; Lam Y
ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
[TBL] [Abstract][Full Text] [Related]
5. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
[TBL] [Abstract][Full Text] [Related]
6. West Nile Virus NS2B/NS3 protease as an antiviral target.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
[TBL] [Abstract][Full Text] [Related]
7. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
8. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
Schöne T; Grimm LL; Sakai N; Zhang L; Hilgenfeld R; Peters T
Antiviral Res; 2017 Oct; 146():174-183. PubMed ID: 28927677
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
Gao Y; Samanta S; Cui T; Lam Y
ChemMedChem; 2013 Sep; 8(9):1554-60. PubMed ID: 23868614
[TBL] [Abstract][Full Text] [Related]
10. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus.
Johnston PA; Phillips J; Shun TY; Shinde S; Lazo JS; Huryn DM; Myers MC; Ratnikov BI; Smith JW; Su Y; Dahl R; Cosford ND; Shiryaev SA; Strongin AY
Assay Drug Dev Technol; 2007 Dec; 5(6):737-50. PubMed ID: 18181690
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue.
Behnam MA; Graf D; Bartenschlager R; Zlotos DP; Klein CD
J Med Chem; 2015 Dec; 58(23):9354-70. PubMed ID: 26562070
[TBL] [Abstract][Full Text] [Related]
12. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
13. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease.
Hammamy MZ; Haase C; Hammami M; Hilgenfeld R; Steinmetzer T
ChemMedChem; 2013 Feb; 8(2):231-41. PubMed ID: 23307694
[TBL] [Abstract][Full Text] [Related]
15. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
[TBL] [Abstract][Full Text] [Related]
16. Detection and in-cell selectivity profiling of the full-length West Nile virus NS2B/NS3 serine protease using membrane-anchored fluorescent substrates.
Condotta SA; Martin MM; Boutin M; Jean F
Biol Chem; 2010 May; 391(5):549-59. PubMed ID: 20302513
[TBL] [Abstract][Full Text] [Related]
17. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
[TBL] [Abstract][Full Text] [Related]
19. NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease.
Su XC; Ozawa K; Yagi H; Lim SP; Wen D; Ekonomiuk D; Huang D; Keller TH; Sonntag S; Caflisch A; Vasudevan SG; Otting G
FEBS J; 2009 Aug; 276(15):4244-55. PubMed ID: 19583774
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.
Tiew KC; Dou D; Teramoto T; Lai H; Alliston KR; Lushington GH; Padmanabhan R; Groutas WC
Bioorg Med Chem; 2012 Feb; 20(3):1213-21. PubMed ID: 22249124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
